Data from first DMT-assisted clinical trial revealed
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial
Read More
Author: John Pinching
Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine
Pharma giants take major stride as vaccine shows significant increase in neutralising antibodies
Read More
Greater tolerance: Allergic reactions to COVID vaccine lower for second dose
Researchers discovered that recipients experiencing an allergic response to second COVID vaccine dose are minimal
Read More
Haleon days: GSK explains demerger decision
New company Haleon will become standalone venture as GSK’s strategy for the future unfolds
Read More
Victory Road: NHS successful in 11 year claim against Servier
The European Commission finds that Servier committed a breach of competition over blood pressure drug
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
